Financials data is unavailable for this security.
View more
Year on year Inovio Pharmaceuticals Inc had revenues fall -91.89% from 10.26m to 832.01k, though the company grew net income from a loss of 279.82m to a smaller loss of 135.12m.
| Gross margin | -- |
|---|---|
| Net profit margin | -20,552.24% |
| Operating margin | -21,563.99% |
| Return on assets | -66.32% |
|---|---|
| Return on equity | -91.42% |
| Return on investment | -84.33% |
More ▼
Cash flow in USDView more
In 2023, cash reserves at Inovio Pharmaceuticals Inc fell by 32.02m. However, Cash Flow from Investing totalled 87.36m, indicating this company earned more from the sale of existing assets than it spent on the purchase of new assets. In addition the company used 124.37m for operations while cash generated from financing totalled 5.00m.
| Cash flow per share | -5.00 |
|---|---|
| Price/Cash flow per share | -- |
| Book value per share | 3.73 |
|---|---|
| Tangible book value per share | 3.73 |
More ▼
Balance sheet in USDView more
| Current ratio | 4.45 |
|---|---|
| Quick ratio | -- |
| Total debt/total equity | 0.00 |
|---|---|
| Total debt/total capital | 0.00 |
More ▼
